Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis.

Literature DB >> 27236709

Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis.

Elena Campello¹, Alberto Zanetto², Luca Spiezia¹, Claudia M Radu¹, Sabrina Gavasso¹, Alberto Ferrarese², Fabio Farinati², Marco Senzolo², Paolo Simioni³.

Abstract

Entities: Disease Species

Mesh：

Year: 2016 PMID： 27236709 DOI： 10.1016/j.thromres.2016.05.021

Source DB: PubMed Journal: Thromb Res ISSN： 0049-3848 Impact factor: 3.944

Keyword Cloud
Cited

× No keyword cloud information.

10 in total

1. Clinical significance of circulating microparticles in Ph^- myeloproliferative neoplasms.

Authors: Wenjuan Zhang; Jiaqian Qi; Shixiang Zhao; Wenhong Shen; Lan Dai; Wei Han; Man Huang; Zhaoyue Wang; Changgeng Ruan; Depei Wu; Yue Han
Journal: Oncol Lett Date: 2017-06-22 Impact factor: 2.967

2. Caspase Inhibition Reduces Hepatic Tissue Factor-Driven Coagulation In Vitro and In Vivo.

Authors: Anna K Kopec; Alfred P Spada; Patricia C Contreras; Nigel Mackman; James P Luyendyk
Journal: Toxicol Sci Date: 2018-04-01 Impact factor: 4.849

Review 3. Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures.

Authors: Mallorie Boron; Tiffany Hauzer-Martin; Joseph Keil; Xue-Long Sun
Journal: TH Open Date: 2022-07-11

4. HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection.

Authors: Valeria Abbate; Margherita Marcantoni; Felice Giuliante; Fabio M Vecchio; Ilaria Gatto; Caterina Mele; Antonio Saviano; Damiano Arciuolo; Eleonora Gaetani; Maria C Ferrari; Igor Giarretta; Francesco Ardito; Laura Riccardi; Alberto Nicoletti; Francesca R Ponziani; Antonio Gasbarrini; Maurizio Pompili; Roberto Pola
Journal: Int J Mol Sci Date: 2017-05-12 Impact factor: 5.923

5. More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC.

Authors: Marco Senzolo; Paolo Simioni; Alberto Zanetto; Elena Campello; Cristiana Bulato; Sabrina Gavasso; Graziella Saggiorato; Sarah Shalaby; Luca Spiezia; Umberto Cillo; Fabio Farinati; Francesco Paolo Russo; Patrizia Burra
Journal: Hepatol Commun Date: 2021-08-16

6. Association of Preoperative Coagulability With Incidence and Extent of Portal Vein Tumor Thrombus and Survival Outcomes in Hepatocellular Carcinoma After Hepatectomy: A Large-Scale, Multicenter Study.

Authors: Xiu-Ping Zhang; Teng-Fei Zhou; Jin-Kai Feng; Zi-Yang Sun; Zuo-Jun Zhen; Dong Zhou; Fan Zhang; Yi-Ren Hu; Cheng-Qian Zhong; Zhen-Hua Chen; Zong-Tao Chai; Kang Wang; Jie Shi; Wei-Xing Guo; Meng-Chao Wu; Wan Yee Lau; Shu-Qun Cheng
Journal: Front Oncol Date: 2021-07-28 Impact factor: 6.244

Review 10. The contact system in liver injury.

Authors: Chandini Rangaswamy; Reiner K Mailer; Hanna Englert; Sandra Konrath; Thomas Renné
Journal: Semin Immunopathol Date: 2021-06-14 Impact factor: 9.623

10 in total

Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis.

1. Clinical significance of circulating microparticles in Ph^- myeloproliferative neoplasms.

2. Caspase Inhibition Reduces Hepatic Tissue Factor-Driven Coagulation In Vitro and In Vivo.

Review 3. Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures.

4. HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection.

5. More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC.

6. Association of Preoperative Coagulability With Incidence and Extent of Portal Vein Tumor Thrombus and Survival Outcomes in Hepatocellular Carcinoma After Hepatectomy: A Large-Scale, Multicenter Study.

Review 7. Extracellular Vesicles Linking Inflammation, Cancer and Thrombotic Risks.

Review 8. Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma.

9. Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma.

Review 10. The contact system in liver injury.

Hypercoagulability detected by circulating microparticles in patients with hepatocellular carcinoma and cirrhosis.

1. Clinical significance of circulating microparticles in Ph- myeloproliferative neoplasms.

2. Caspase Inhibition Reduces Hepatic Tissue Factor-Driven Coagulation In Vitro and In Vivo.

Review 3. Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures.

4. HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection.

5. More Pronounced Hypercoagulable State and Hypofibrinolysis in Patients With Cirrhosis With Versus Without HCC.

6. Association of Preoperative Coagulability With Incidence and Extent of Portal Vein Tumor Thrombus and Survival Outcomes in Hepatocellular Carcinoma After Hepatectomy: A Large-Scale, Multicenter Study.

Review 7. Extracellular Vesicles Linking Inflammation, Cancer and Thrombotic Risks.

Review 8. Cancer-Associated Thrombosis in Cirrhotic Patients with Hepatocellular Carcinoma.

9. Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma.

Review 10. The contact system in liver injury.

1. Clinical significance of circulating microparticles in Ph^- myeloproliferative neoplasms.